Double Expressor Lymphoma
📧 Sign up to get email alerts when something new happens for Double Expressor Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Safety of Anti-Cancer Drug, CX-5461 (Pidnarulex), in Treating Lymphoma With Specific Changes in the MYC Gene [Phase 1, Phase 2]
An NCI-sponsored clinical trial is evaluating the safety of CX-5461 (Pidnarulex) in lymphomas with MYC alterations, including Burkitt lympho…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell Lymphomas [Phase 2, Phase 3]
A Phase 2/Phase 3 trial is evaluating adding venetoclax to standard chemotherapy for high-grade B-cell lymphomas, including diffuse large B-…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Study Comparing C Pola R-CHP+X With CR-CHOP in the Treatment of Previously Untreated DEL Under the Guidance of Genotyping [Phase 3]
Phase 3 trial comparing C Pola R-CHP+X versus CR-CHOP for previously untreated double-expressor diffuse large B-cell lymphoma under genotypi…
-
CLINICAL_TRIALS trial_result · 2025-09-29Clinical Trial Update: Polatuzumab Vedotin and Combination Chemotherapy for the Treatment of Previously Untreated Lymphoma [Phase 2]
A Phase 2 clinical trial update notes Polatuzumab Vedotin in combination chemotherapy for previously untreated diffuse large B-cell lymphoma…